Advertisement

Topics

Search Results for "Tingkatan Satu Sejarah Nota"

21:52 EST 5th December 2016 | BioPortfolio

Matching Channels

None

Matching News

ValiRx's sale of Finnish subsidiary will free up resources

Life sciences firm ValiRx Plc (LON:VAL) says it has streamlined operations by selling its Finnish subsidiary ValiFinn to Sovicell Science for Life GmbH for €800,000 in cash. It will however retain...

ValiRx's recent data well received

Recent presentations from life sciences firm ValiRx Plc (LON:VAL) have been warmly received, the group said in an update. The company has two drugs in clinical trials, VAL 201 for prostate cancer, a...

ValiRx receives new patents in Japan and US for lead compounds

Cancer-focused biotech ValiRx Plc (LON:VAL) says its technology has been further endorsed with the award of new patents in Japan and the US. The patents relate to the firm's compounds VAL201 and VAL...

Green-light received for start of ValiRx's lung cancer trial

Cancer treatments developer ValiRx Plc (LON:VAL) said its joint venture ValiSeek has received the green light to start trials of a lung cancer drug. ValiSeek has received notification of acceptance ...

Georgian authorities give green-light for start of ValiRx's lung cancer trial

Cancer treatments developer ValiRx Plc (LON:VAL) said its joint venture ValiSeek has received the green light to start trials of a lung cancer drug. ValiSeek has received notification of acceptance ...

Philips showcases commitment to helping the world sleep better with innovative sleep-disordered breathing solutions and light therapy innovations at IFA

BERLIN, Sept. 1, 2016 /PRNewswire/ -- At this year's Internationale Funkausstellung (IFA), taking place in Berlin, Germany from September 2-7, Royal Philips (NYSE: PHG, AEX: PHIA) is presenting innova...

'A little more action': Elvis tribute artist takes control of health to fulfill dream

MEMPHIS, Tenn., Aug. 12, 2016 /PRNewswire/ -- Royal Philips (NYSE:PHG, AEX: PHIA) today (August 12, 2016) unveiled 'A little more action' at Elvis Week in Memphis, Tennessee. 'A little more action' te...

Ibrutinib (IMBRUVICA®) Supplemental New Drug Application Submitted to the U.S. Food and Drug Administration (FDA) for Marginal Zone Lymphoma (MZL)

RARITAN, N.J., Sept. 26, 2016 /PRNewswire/ -- Janssen Research & Development, LLC announced today that a supplemental New Drug Application (sNDA) for ibrutinib (IMBRUVICA®) has been subm...

Matching PubMed Articles

Evaluation of a Flexible NOTA-RGD Kit Solution Using Gallium-68 from Different (68)Ge/(68)Ga-Generators: Pharmacokinetics and Biodistribution in Nonhuman Primates and Demonstration of Solitary Pulmonary Nodule Imaging in Humans.

Radiopharmaceuticals containing the motive tripeptide arginyl-glycyl-asparatic acid (RGD) are known to target ανβ3 integrins during tumor angiogenesis. A more generic kit radiolabeling procedure ac...

Targeting phosphatidylserine with a 64Cu-labeled peptide for molecular imaging of apoptosis.

Molecular imaging of programmed cell death (apoptosis) in vivo is an innovative strategy for early assessment of treatment response and treatment efficacy in cancer patients. Externalization of phosph...

Prognostic Value of 68Ga-NOTA-RGD PET/CT for Predicting Disease-Free Survival for Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy and Surgery: A Comparison Study With Dynamic Contrast Enhanced MRI.

We performed pretreatment angiogenesis imaging (Ga-NOTA-arginyl-glycyl-aspartic acid [RGD] PET/CT) to compare its prognostic value to dynamic contrast-enhanced (DCE) MRI in breast cancer patients.

Miscommunicating NOTA can be Costly to Living Donors.

Misconceptions about if and how living donors may receive financial support appear to be widespread. These misconceptions may be perpetuated by unclear or incomplete language in informed consent docum...

The feasibility of 18F-AlF-NOTA-PRGD2 PET/CT for monitoring early response of Endostar antiangiogenic therapy in human nasopharyngeal carcinoma xenograft model compared with 18F-FDG.

Radiolabeled arginine-glycine-aspartic acid (RGD) peptides have been developed for PET imaging of integrin avβ3 in the tumor vasculature, leading to great potential for noninvasively evaluating tumor...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement